文献速递血液透析通路

长段补片血管成形术促进动静脉瘘成熟的新技术

A novel technique using long segment patch angioplasty maturation to increase the maturation rate of arteriovenous fistulas.
PubMed 文献 · J Vasc Surg · 2021-04-21

单中心回顾性队列研究纳入139例成熟失败的自体动静脉瘘患者,采用牛心包补片行长段补片血管成形术促成熟。137例可随访者中126例(92.0%)成功成熟,1、2、3年辅助一级通畅率分别为87.3%、78.1%、68.0%。

要点

  • 长段牛心包补片血管成形术可使92.0%的成熟失败动静脉瘘成功成熟。
  • 术后1、2、3年辅助一级通畅率分别为87.3%、78.1%、68.0%。
  • 54.8%的患者术后无需额外干预,需干预者平均间隔4.56个月。

核心结论

  • 长段牛心包补片血管成形术可安全用于治疗成熟失败的动静脉瘘,成熟成功率达92.0%,通畅率与自体动静脉瘘相当。

研究设计与样本

  • 单中心回顾性队列研究,2007年3月至2019年10月共139例成熟失败的自体动静脉瘘患者接受补片血管成形术促成熟。
  • 使用2cm×9cm或2.5cm×15cm长段牛心包补片行血管成形术。
  • 137例(98.6%)获得随访数据,以死亡和末次随访日期为删失进行 Kaplan-Meier 分析。

主要发现

  • 137例可随访患者中126例(92.0%)动静脉瘘进展至成熟。
  • 126例成熟患者中88例既往透析方式已知,其中70例(79.5%)此前经血液透析导管透析。
  • 1、2、3年辅助一级通畅率分别为87.3%、78.1%、68.0%。
  • 137例中69例(54.8%)补片血管成形术后无需额外干预。
  • 需干预的并发症包括狭窄45例(32.8%)、血栓形成10例(7.3%)、感染3例(2.2%)、窃血综合征3例(2.2%)、非感染性伤口并发症1例(0.8%)和假性动脉瘤1例(0.8%)。

关键数值与推荐

  • 补片血管成形术后至需干预的平均间隔为4.56个月。
  • 需干预并发症发生率:狭窄32.8%、血栓形成7.3%、感染2.2%、窃血综合征2.2%。

临床怎么用

  • 对于成熟失败的自体动静脉瘘,可考虑采用长段牛心包补片血管成形术促成熟。
  • 术后需监测狭窄和血栓形成,必要时及时干预。

局限性

  • 单中心回顾性研究设计。
  • 部分患者既往透析方式数据缺失(126例中仅88例已知)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Given the superior patency of arteriovenous fistulas (AVFs) and the decreased risk of infection compared with arteriovenous grafts, the Kidney Disease Outcomes Quality Initiative guidelines have recommended the fistula-first approach. However, ∼20% to 60% of all fistulas will fail to mature. We have described our experience with a novel technique using bovine pericardial patch angioplasty to increase the rate of AVF maturation. METHODS: We used 2-cm × 9-cm-long or 2.5-cm × 15-cm-long segment pericardial patch angioplasty to assist in the maturation of AVFs. A single-center, retrospective cohort study was conducted of all patients who had undergone patch angioplasty maturation (PAM) for AVFs that had failed to mature. The outcomes of interest were maturation status and patency, censored by the death and last known follow-up dates. RESULTS: From March 2007 to October 2019, 139 patients had undergone PAM. Follow-up data were available for 137 of the 139 patients (98.6%), with 126 AVFs (92.0%) progressing to maturation. Of the 126 patients with AVFs that had progressed to maturity, the previous hemodialysis (HD) method was known for 88 patients (69.8%). Of these 88 patients, 70 (79.5%) had previously been receiving HD via an HD catheter. Using a Kaplan-Meier estimator censored for death and loss to follow-up, the assisted primary patency rates at 1, 2, and 3 years were 87.3%, 78.1%, and 68.0%, respectively. Of the 137 patients, 69 (54.8%) had required no additional interventions after patch angioplasty. The complications requiring intervention were stenosis (n = 45; 32.8%), thrombosis (n = 10; 7.3%), infection (n = 3; 2.2%), steal syndrome (n = 3; 2.2%), noninfected wound complications (n = 1; 0.8%), and pseudoaneurysm (n = 1; 0.8%). The average interval to intervention after patch angioplasty was 4.56 months. CONCLUSIONS: Long-segment bovine pericardial PAM can be performed safely to treat nonmaturing AVFs, with a 92.0% successful maturation rate and patency rates comparable to those for AVFs. PAM should be a consideration for patients with nonmaturing AVFs.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Parker MH, Hashemi H, Grant C, et al. A novel technique using long segment patch angioplasty maturation to increase the maturation rate of arteriovenous fistulas. J Vasc Surg. 2021. PMID: 33348009. doi:10.1016/j.jvs.2020.12.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。